Zinc in PDB 6mon: Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor
Enzymatic activity of Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor
All present enzymatic activity of Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor:
2.1.1.43;
Protein crystallography data
The structure of Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor, PDB code: 6mon
was solved by
N.Spellmon,
E.Cornett,
J.Brunzelle,
S.Rothbart,
Z.Yang,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
51.24 /
2.71
|
Space group
|
P 42
|
Cell size a, b, c (Å), α, β, γ (°)
|
153.728,
153.728,
53.457,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
21.1 /
22.7
|
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor
(pdb code 6mon). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 6 binding sites of Zinc where determined in the
Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor, PDB code: 6mon:
Jump to Zinc binding site number:
1;
2;
3;
4;
5;
6;
Zinc binding site 1 out
of 6 in 6mon
Go back to
Zinc Binding Sites List in 6mon
Zinc binding site 1 out
of 6 in the Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn501
b:68.6
occ:1.00
|
SG
|
A:CYS78
|
2.3
|
65.8
|
1.0
|
SG
|
A:CYS74
|
2.3
|
66.0
|
1.0
|
SG
|
A:CYS55
|
2.3
|
69.5
|
1.0
|
SG
|
A:CYS52
|
2.4
|
68.6
|
1.0
|
CB
|
A:CYS52
|
3.2
|
67.7
|
1.0
|
CB
|
A:CYS74
|
3.2
|
71.1
|
1.0
|
CB
|
A:CYS78
|
3.4
|
68.4
|
1.0
|
CB
|
A:CYS55
|
3.5
|
56.5
|
1.0
|
N
|
A:CYS74
|
3.9
|
68.9
|
1.0
|
N
|
A:CYS55
|
3.9
|
58.1
|
1.0
|
CA
|
A:CYS74
|
4.1
|
72.9
|
1.0
|
CA
|
A:CYS55
|
4.3
|
56.7
|
1.0
|
OG1
|
A:THR57
|
4.5
|
70.3
|
1.0
|
CA
|
A:CYS52
|
4.7
|
63.2
|
1.0
|
CB
|
A:THR57
|
4.7
|
63.9
|
1.0
|
CB
|
A:TYR54
|
4.7
|
62.4
|
1.0
|
CA
|
A:CYS78
|
4.8
|
74.3
|
1.0
|
C
|
A:CYS55
|
4.9
|
50.4
|
1.0
|
C
|
A:TYR54
|
5.0
|
58.0
|
1.0
|
CD1
|
A:TYR54
|
5.0
|
62.7
|
1.0
|
|
Zinc binding site 2 out
of 6 in 6mon
Go back to
Zinc Binding Sites List in 6mon
Zinc binding site 2 out
of 6 in the Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn502
b:63.9
occ:1.00
|
NE2
|
A:HIS86
|
2.1
|
54.6
|
1.0
|
SG
|
A:CYS68
|
2.3
|
58.7
|
1.0
|
SG
|
A:CYS90
|
2.3
|
62.0
|
1.0
|
SG
|
A:CYS65
|
2.4
|
67.8
|
1.0
|
CD2
|
A:HIS86
|
3.0
|
59.2
|
1.0
|
CE1
|
A:HIS86
|
3.1
|
58.0
|
1.0
|
CB
|
A:CYS90
|
3.3
|
57.9
|
1.0
|
CB
|
A:CYS68
|
3.4
|
62.1
|
1.0
|
CB
|
A:CYS65
|
3.5
|
69.1
|
1.0
|
N
|
A:CYS68
|
3.7
|
70.3
|
1.0
|
CA
|
A:CYS90
|
4.0
|
51.0
|
1.0
|
CA
|
A:CYS68
|
4.1
|
68.1
|
1.0
|
CG
|
A:HIS86
|
4.1
|
57.6
|
1.0
|
ND1
|
A:HIS86
|
4.2
|
58.5
|
1.0
|
CB
|
A:ARG67
|
4.5
|
76.3
|
1.0
|
CB
|
A:ALA71
|
4.7
|
65.6
|
1.0
|
NH1
|
A:ARG67
|
4.8
|
92.3
|
1.0
|
C
|
A:ARG67
|
4.8
|
71.4
|
1.0
|
C
|
A:CYS90
|
4.9
|
60.2
|
1.0
|
CA
|
A:CYS65
|
4.9
|
73.3
|
1.0
|
CZ3
|
A:TRP83
|
4.9
|
63.8
|
1.0
|
N
|
A:ARG67
|
4.9
|
73.1
|
1.0
|
N
|
A:LYS69
|
5.0
|
71.6
|
1.0
|
CA
|
A:ARG67
|
5.0
|
70.6
|
1.0
|
|
Zinc binding site 3 out
of 6 in 6mon
Go back to
Zinc Binding Sites List in 6mon
Zinc binding site 3 out
of 6 in the Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn503
b:65.7
occ:1.00
|
SG
|
A:CYS267
|
2.3
|
65.6
|
1.0
|
SG
|
A:CYS262
|
2.3
|
61.8
|
1.0
|
SG
|
A:CYS209
|
2.3
|
51.8
|
1.0
|
SG
|
A:CYS264
|
2.3
|
64.4
|
1.0
|
CB
|
A:CYS209
|
3.1
|
67.7
|
1.0
|
CB
|
A:CYS262
|
3.2
|
55.3
|
1.0
|
CB
|
A:CYS267
|
3.5
|
72.9
|
1.0
|
CB
|
A:CYS264
|
3.5
|
59.9
|
1.0
|
N
|
A:CYS209
|
3.6
|
55.4
|
1.0
|
CA
|
A:CYS209
|
4.0
|
63.1
|
1.0
|
N
|
A:CYS267
|
4.0
|
73.7
|
1.0
|
N
|
A:CYS264
|
4.0
|
65.5
|
1.0
|
NH2
|
A:ARG250
|
4.1
|
66.2
|
1.0
|
CA
|
A:CYS264
|
4.3
|
65.4
|
1.0
|
CA
|
A:CYS267
|
4.3
|
75.9
|
1.0
|
CA
|
A:CYS262
|
4.5
|
60.2
|
1.0
|
C
|
A:CYS262
|
4.5
|
65.6
|
1.0
|
NE
|
A:ARG250
|
4.6
|
65.3
|
1.0
|
C
|
A:SER208
|
4.7
|
56.2
|
1.0
|
NE2
|
A:HIS207
|
4.7
|
58.0
|
1.0
|
CB
|
A:GLU266
|
4.8
|
82.8
|
1.0
|
O
|
A:CYS262
|
4.8
|
70.2
|
1.0
|
N
|
A:GLU263
|
4.8
|
64.8
|
1.0
|
C
|
A:CYS264
|
4.9
|
69.7
|
1.0
|
CZ
|
A:ARG250
|
4.9
|
69.0
|
1.0
|
CD2
|
A:HIS207
|
4.9
|
52.8
|
1.0
|
O
|
A:CYS264
|
5.0
|
72.1
|
1.0
|
|
Zinc binding site 4 out
of 6 in 6mon
Go back to
Zinc Binding Sites List in 6mon
Zinc binding site 4 out
of 6 in the Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn501
b:76.7
occ:1.00
|
SG
|
B:CYS78
|
2.2
|
75.8
|
1.0
|
SG
|
B:CYS55
|
2.3
|
72.6
|
1.0
|
SG
|
B:CYS74
|
2.4
|
92.5
|
1.0
|
SG
|
B:CYS52
|
2.4
|
73.4
|
1.0
|
CB
|
B:CYS74
|
3.2
|
78.5
|
1.0
|
CB
|
B:CYS52
|
3.3
|
68.2
|
1.0
|
CB
|
B:CYS78
|
3.4
|
81.7
|
1.0
|
CB
|
B:CYS55
|
3.5
|
72.5
|
1.0
|
N
|
B:CYS74
|
3.9
|
79.7
|
1.0
|
N
|
B:CYS55
|
3.9
|
64.8
|
1.0
|
CA
|
B:CYS74
|
4.1
|
82.7
|
1.0
|
CA
|
B:CYS55
|
4.3
|
63.5
|
1.0
|
OG1
|
B:THR57
|
4.5
|
72.0
|
1.0
|
CB
|
B:THR57
|
4.7
|
71.4
|
1.0
|
CB
|
B:TYR54
|
4.7
|
72.7
|
1.0
|
CA
|
B:CYS78
|
4.8
|
80.0
|
1.0
|
CA
|
B:CYS52
|
4.8
|
65.8
|
1.0
|
CD1
|
B:TYR54
|
4.9
|
74.4
|
1.0
|
C
|
B:TYR54
|
5.0
|
66.5
|
1.0
|
C
|
B:CYS55
|
5.0
|
58.9
|
1.0
|
|
Zinc binding site 5 out
of 6 in 6mon
Go back to
Zinc Binding Sites List in 6mon
Zinc binding site 5 out
of 6 in the Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 5 of Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn502
b:64.6
occ:1.00
|
NE2
|
B:HIS86
|
2.0
|
65.6
|
1.0
|
SG
|
B:CYS68
|
2.2
|
64.8
|
1.0
|
SG
|
B:CYS90
|
2.3
|
67.9
|
1.0
|
SG
|
B:CYS65
|
2.4
|
71.5
|
1.0
|
CD2
|
B:HIS86
|
2.9
|
62.1
|
1.0
|
CE1
|
B:HIS86
|
3.1
|
64.4
|
1.0
|
CB
|
B:CYS90
|
3.4
|
63.8
|
1.0
|
CB
|
B:CYS68
|
3.4
|
60.5
|
1.0
|
CB
|
B:CYS65
|
3.6
|
81.7
|
1.0
|
N
|
B:CYS68
|
3.8
|
78.5
|
1.0
|
CA
|
B:CYS90
|
4.0
|
59.7
|
1.0
|
CG
|
B:HIS86
|
4.1
|
62.9
|
1.0
|
ND1
|
B:HIS86
|
4.2
|
58.8
|
1.0
|
CA
|
B:CYS68
|
4.2
|
75.4
|
1.0
|
CB
|
B:ALA71
|
4.6
|
70.0
|
1.0
|
CB
|
B:ARG67
|
4.6
|
86.4
|
1.0
|
NH1
|
B:ARG67
|
4.8
|
95.9
|
1.0
|
C
|
B:CYS90
|
4.9
|
59.1
|
1.0
|
CZ3
|
B:TRP83
|
4.9
|
69.8
|
1.0
|
C
|
B:ARG67
|
4.9
|
84.1
|
1.0
|
CA
|
B:CYS65
|
4.9
|
76.4
|
1.0
|
|
Zinc binding site 6 out
of 6 in 6mon
Go back to
Zinc Binding Sites List in 6mon
Zinc binding site 6 out
of 6 in the Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 6 of Crystal Structure of Human SMYD2 in Complex with Nle-Peptide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn503
b:66.7
occ:1.00
|
SG
|
B:CYS262
|
2.2
|
56.7
|
1.0
|
SG
|
B:CYS267
|
2.3
|
72.6
|
1.0
|
SG
|
B:CYS209
|
2.3
|
63.3
|
1.0
|
SG
|
B:CYS264
|
2.4
|
78.1
|
1.0
|
CB
|
B:CYS209
|
3.1
|
69.0
|
1.0
|
CB
|
B:CYS262
|
3.1
|
53.2
|
1.0
|
CB
|
B:CYS267
|
3.5
|
73.8
|
1.0
|
CB
|
B:CYS264
|
3.5
|
70.3
|
1.0
|
N
|
B:CYS209
|
3.6
|
60.0
|
1.0
|
N
|
B:CYS264
|
4.0
|
68.9
|
1.0
|
CA
|
B:CYS209
|
4.0
|
64.6
|
1.0
|
N
|
B:CYS267
|
4.0
|
70.5
|
1.0
|
CA
|
B:CYS264
|
4.2
|
70.8
|
1.0
|
NH2
|
B:ARG250
|
4.3
|
73.0
|
1.0
|
CA
|
B:CYS267
|
4.3
|
69.0
|
1.0
|
CA
|
B:CYS262
|
4.4
|
60.1
|
1.0
|
C
|
B:CYS262
|
4.4
|
70.7
|
1.0
|
C
|
B:SER208
|
4.7
|
60.5
|
1.0
|
NE2
|
B:HIS207
|
4.7
|
53.3
|
1.0
|
NE
|
B:ARG250
|
4.7
|
68.8
|
1.0
|
O
|
B:CYS262
|
4.7
|
72.1
|
1.0
|
N
|
B:GLU263
|
4.8
|
67.4
|
1.0
|
C
|
B:CYS264
|
4.8
|
74.8
|
1.0
|
CB
|
B:GLU266
|
4.9
|
78.0
|
1.0
|
O
|
B:CYS264
|
4.9
|
76.5
|
1.0
|
CD2
|
B:HIS207
|
4.9
|
53.0
|
1.0
|
CA
|
B:SER208
|
5.0
|
60.8
|
1.0
|
CZ
|
B:ARG250
|
5.0
|
70.0
|
1.0
|
|
Reference:
E.M.Cornett,
B.M.Dickson,
K.Krajewski,
N.Spellmon,
A.Umstead,
R.M.Vaughan,
K.M.Shaw,
P.P.Versluis,
M.W.Cowles,
J.Brunzelle,
Z.Yang,
I.E.Vega,
Z.W.Sun,
S.B.Rothbart.
A Functional Proteomics Platform to Reveal the Sequence Determinants of Lysine Methyltransferase Substrate Selectivity. Sci Adv V. 4 V2623 2018.
ISSN: ESSN 2375-2548
PubMed: 30498785
DOI: 10.1126/SCIADV.AAV2623
Page generated: Tue Oct 29 03:19:49 2024
|